Cancer
Gastric Cancer Research Reveals Promising Outcomes for Trastuzumab Therapy
A new study has shed light on the efficacy and safety of trastuzumab plus chemo(immuno)therapy for patients with potentially resectable HER2-positive gastric cancer. Research conducted at the Affiliated Hospital of Qingdao University in China revealed that the addition of trastuzumab to preoperative chemotherapy or chemoimmunotherapy resulted in a